Accueil › Cancer du côlon › New York › New York City
Essais cliniques pour Cancer du côlon à New York City, NY
22 études pour Cancer du côlon recherchent des participants dans et autour de New York City (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Recrutement en coursPhase 3
- Memorial Sloan Kettering Cancer Center ( Site 0095), New York
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Recrutement en coursPhase 3
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New York
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Recrutement en coursPhase 1/2
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Recrutement en coursPhase 1/2
- NYU Langone Health Perlmutter Cancer Center, New York
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Recrutement en coursPhase 3
- Icahn School of Medicine At Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Recrutement en cours
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Recrutement en coursPhase 2/3
- Mount Sinai West, New York
- Mount Sinai Hospital, New York
- Manhattan Eye Ear and Throat Hospital, New York
- et 2 autres
Shield Post-Approval Study Protocol
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- NYU Langone, New York
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Recrutement en coursPhase 1
- Xencor Investigative Site, New York
- Xencor Investigative Site, New York
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Memorial Sloan Kettering Cancer Center 53rd street., New York
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Recrutement en coursPhase 1/2
- NYU Langone Medical Center, New York
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Recrutement en coursPhase 1
- Research Site, New York
- Research Site, New York
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Recrutement en coursPhase 1
- NYU Langone, New York
- Memorial Sloan Kettering Cancer Center, New York
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Recrutement en coursPhase 1/2
- Perlmutter Cancer Center at NYU Langone Health, New York
- Memorial Sloan-Kettering Cancer Center, New York
- Columbia University, New York
Brodalumab in the Treatment of Immune-Related Adverse Events
Recrutement en coursPhase 1
- Columbia University Irving Medical Center, New York
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
Recrutement en coursÉtude observationnelle
- NYU Langone Health, New York
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
Recrutement en coursÉtude observationnelle
- Memorial Sloan Kettering Cancer Center, New York
Phase II Trial of Lung Chemoemobolization
Recrutement en coursPhase 2
- Memorial Sloan Kettering Cancer Center, New York
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Memorial Sloan Kettering Cancer Center, New York
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Recrutement en coursPhase 3
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- GSK Investigational Site, New York
- et 1 autres
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recrutement en coursÉtude observationnelle
- Massive Bio SYNERGY-AI site, New York
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Recrutement en coursPhase 1/2
- NYU Langone Health, New York
Essais pour Cancer du côlon dans d'autres villes
- Boston, MA22 études
- Houston, TX20 études
- Los Angeles, CA16 études
- Nashville, TN16 études
- St. Louis, MO15 études
- Arlington, VA15 études
- Chicago, IL14 études
- San Antonio, TX14 études
- Baldwin Park, CA14 études
- Baltimore, MD13 études
- Tampa, FL13 études
- Washington, DC12 études
Autres études à New York City
- Cancer du sein136 études
- Cancer du poumon non à petites cellules121 études
- Cancer (tous types)109 études
- Cancer de la prostate103 études
- Cancer métastatique93 études
- Cancer colorectal78 études
- Cancer de l'ovaire69 études
- Cancer du poumon60 études
- Myélome multiple60 études
- Cancer du pancréas60 études
- Cancer de l'endomètre52 études
- Leucémie aiguë myéloïde51 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.